Peter Michael Mowschenson, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proctocolectomy, Restorative | 5 | 2019 | 189 | 0.650 |
Why?
|
Ileostomy | 4 | 2017 | 119 | 0.350 |
Why?
|
Thyroidectomy | 5 | 2021 | 879 | 0.320 |
Why?
|
Thyroid Neoplasms | 5 | 2021 | 2282 | 0.310 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2021 | 324 | 0.260 |
Why?
|
Hyperparathyroidism | 4 | 2011 | 339 | 0.250 |
Why?
|
Ambulatory Surgical Procedures | 4 | 1999 | 454 | 0.230 |
Why?
|
Rectum | 2 | 2019 | 904 | 0.230 |
Why?
|
Parathyroidectomy | 4 | 2011 | 235 | 0.220 |
Why?
|
Colitis, Ulcerative | 5 | 2019 | 1912 | 0.200 |
Why?
|
Cholecystectomy, Laparoscopic | 2 | 1993 | 230 | 0.190 |
Why?
|
Colonic Pouches | 2 | 2019 | 121 | 0.190 |
Why?
|
Carcinoma | 3 | 2021 | 2375 | 0.190 |
Why?
|
Technetium Tc 99m Sestamibi | 3 | 2013 | 177 | 0.180 |
Why?
|
Dysphonia | 1 | 2021 | 144 | 0.170 |
Why?
|
Parathyroid Neoplasms | 2 | 2011 | 245 | 0.160 |
Why?
|
Thyroid Gland | 2 | 1995 | 1173 | 0.160 |
Why?
|
Adenoma | 3 | 2016 | 2174 | 0.140 |
Why?
|
Fecal Incontinence | 2 | 2019 | 239 | 0.130 |
Why?
|
Thyroid Nodule | 1 | 2021 | 750 | 0.120 |
Why?
|
Parathyroid Glands | 1 | 1995 | 509 | 0.120 |
Why?
|
Parathyroid Hormone | 2 | 2011 | 1801 | 0.110 |
Why?
|
Surgical Stapling | 3 | 2017 | 97 | 0.110 |
Why?
|
Prospective Payment System | 2 | 1990 | 133 | 0.100 |
Why?
|
Urinary Catheterization | 1 | 1992 | 202 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1859 | 0.100 |
Why?
|
Diagnosis-Related Groups | 2 | 1990 | 455 | 0.100 |
Why?
|
Rate Setting and Review | 1 | 1990 | 41 | 0.090 |
Why?
|
Postoperative Complications | 6 | 2021 | 15295 | 0.090 |
Why?
|
Surgicenters | 1 | 1990 | 46 | 0.090 |
Why?
|
Laparoscopy | 2 | 2017 | 2151 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 1107 | 0.080 |
Why?
|
Health Expenditures | 1 | 2021 | 2348 | 0.080 |
Why?
|
Adipose Tissue, Brown | 1 | 2013 | 757 | 0.080 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2000 | 224 | 0.060 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2010 | 740 | 0.060 |
Why?
|
Diagnostic Errors | 2 | 2007 | 1257 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2016 | 0.060 |
Why?
|
Preoperative Care | 1 | 1992 | 2250 | 0.060 |
Why?
|
Biopsy, Fine-Needle | 2 | 2021 | 1094 | 0.050 |
Why?
|
Esophagogastric Junction | 1 | 1982 | 313 | 0.040 |
Why?
|
Voice Quality | 1 | 2021 | 217 | 0.040 |
Why?
|
Hypercalcemia | 1 | 1982 | 409 | 0.040 |
Why?
|
Adult | 15 | 2021 | 214055 | 0.040 |
Why?
|
Defecation | 1 | 2019 | 188 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6234 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2010 | 2758 | 0.040 |
Why?
|
Carcinoma, Papillary | 2 | 2016 | 783 | 0.040 |
Why?
|
Aged | 11 | 2021 | 163280 | 0.030 |
Why?
|
Urinary Bladder | 2 | 1992 | 1172 | 0.030 |
Why?
|
Middle Aged | 12 | 2021 | 213383 | 0.030 |
Why?
|
Parathyroid Diseases | 1 | 1995 | 48 | 0.030 |
Why?
|
Cholangiography | 2 | 1993 | 189 | 0.030 |
Why?
|
Humans | 27 | 2021 | 744343 | 0.030 |
Why?
|
Medicare | 2 | 1990 | 6566 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2019 | 63114 | 0.030 |
Why?
|
Splenectomy | 1 | 1996 | 395 | 0.030 |
Why?
|
Male | 14 | 2021 | 350118 | 0.030 |
Why?
|
Employment | 1 | 2021 | 1132 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2017 | 987 | 0.030 |
Why?
|
Hospital Costs | 2 | 1999 | 985 | 0.030 |
Why?
|
Blood Circulation | 1 | 2013 | 251 | 0.030 |
Why?
|
Reoperation | 2 | 2009 | 4201 | 0.030 |
Why?
|
Thyroid Diseases | 1 | 1995 | 379 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 77449 | 0.030 |
Why?
|
Female | 13 | 2021 | 380194 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 2009 | 2031 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4037 | 0.020 |
Why?
|
Urine | 1 | 1992 | 370 | 0.020 |
Why?
|
Ascites | 1 | 1992 | 344 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.020 |
Why?
|
Crohn Disease | 1 | 2003 | 2303 | 0.020 |
Why?
|
Common Bile Duct | 1 | 1990 | 109 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3558 | 0.020 |
Why?
|
Quality of Life | 2 | 2021 | 12804 | 0.020 |
Why?
|
Fee Schedules | 1 | 1990 | 86 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1994 | 1641 | 0.020 |
Why?
|
Biological Transport | 1 | 2013 | 2118 | 0.020 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 160 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2494 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2009 | 520 | 0.020 |
Why?
|
Neck Dissection | 1 | 2009 | 197 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 1681 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2009 | 405 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39050 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12959 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2007 | 123 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.020 |
Why?
|
Postpartum Period | 1 | 1992 | 1086 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2021 | 4245 | 0.020 |
Why?
|
Feasibility Studies | 1 | 1995 | 5078 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1992 | 1198 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 1999 | 5391 | 0.020 |
Why?
|
Adolescent | 3 | 2016 | 85781 | 0.020 |
Why?
|
Catheterization | 1 | 1990 | 1470 | 0.020 |
Why?
|
Calcium | 2 | 2011 | 5756 | 0.010 |
Why?
|
Cesarean Section | 1 | 1992 | 1365 | 0.010 |
Why?
|
Prospective Studies | 3 | 2011 | 53288 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
Radiography, Interventional | 1 | 2010 | 1095 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
United States | 3 | 2021 | 69872 | 0.010 |
Why?
|
Time Factors | 2 | 2021 | 40075 | 0.010 |
Why?
|
Heartburn | 1 | 1982 | 68 | 0.010 |
Why?
|
Glucose | 1 | 2013 | 4397 | 0.010 |
Why?
|
Data Collection | 1 | 1990 | 3341 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
Manometry | 1 | 1982 | 445 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2645 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 155 | 0.010 |
Why?
|
Fibrinopeptide A | 1 | 1978 | 44 | 0.010 |
Why?
|
Pressure | 1 | 1982 | 1203 | 0.010 |
Why?
|
Biopsy | 1 | 1990 | 6756 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1978 | 152 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 20947 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5985 | 0.010 |
Why?
|
Spherocytosis, Hereditary | 1 | 1996 | 80 | 0.010 |
Why?
|
Hospitals | 1 | 1990 | 3952 | 0.010 |
Why?
|
Fibrinogen | 1 | 1978 | 894 | 0.010 |
Why?
|
Platelet Activation | 1 | 1978 | 673 | 0.010 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 1996 | 233 | 0.010 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1990 | 111 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 56430 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 1999 | 3396 | 0.000 |
Why?
|
Mice | 1 | 2013 | 81183 | 0.000 |
Why?
|
Thrombosis | 1 | 1978 | 2968 | 0.000 |
Why?
|
Length of Stay | 1 | 1996 | 6309 | 0.000 |
Why?
|
Animals | 1 | 2013 | 168757 | 0.000 |
Why?
|
Recurrence | 1 | 1990 | 8340 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1978 | 919 | 0.000 |
Why?
|
Cardiopulmonary Bypass | 1 | 1978 | 1066 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1990 | 6364 | 0.000 |
Why?
|